S D Life Sciences India Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
- Paid Up Capital ₹ 1.50 Cr
- Company Age 11 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.00 Cr
- Revenue Growth 45.46%
- Profit Growth -7.62%
- Ebitda 13.54%
- Net Worth 8.00%
- Total Assets 141.01%
About S D Life Sciences India
S D Life Sciences India Private Limited (SDLSIPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 July 2013 and has a history of 11 years and seven months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.50 Cr.
The company currently has active open charges totaling ₹3.00 Cr.
Bakka Ashwini and Dharma Bakka serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24231TG2013PTC088854
-
Company No.
088854
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
09 Jul 2013
-
Date of AGM
29 Jan 2024
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at S D Life Sciences India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bakka Ashwini
|
Director | Current | |
|
Dharma Bakka
|
Director | 01-Mar-2024 | Current |
Financial Performance of S D Life Sciences India.
S D Life Sciences India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 45.46% increase. The company also saw a slight decrease in profitability, with a 7.62% decrease in profit. The company's net worth moved up by a moderate rise of 8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of S D Life Sciences India?
In 2023, S D Life Sciences India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Aditus Laboratories LimitedBakka Ashwini is a mutual person
-
Vakiti Pharmaceauticals Private Limited
Bakka Ashwini and Dharma Bakka are mutual person
Charges (Loans)
₹3.00 Cr
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 3.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Mar 2023 | State Bank Of India | ₹3.00 Cr | Open |
How Many Employees Work at S D Life Sciences India?
S D Life Sciences India has a workforce of 17 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of S D Life Sciences India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped S D Life Sciences India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
